头颈癌放疗靶区勾画中的影像学:丹麦DAHANCA国家指南解读
头颈癌高适形放疗中靶区定义面临挑战,PET与MRI多模态影像提供代谢、扩散、缺氧及解剖信息。丹麦DAHANCA组织多学科研讨会制定国家指南,推荐所有肉眼肿瘤根治性放疗计划使用多模态影像,2-[18F]FDG-PET/CT应可获取并最好在治疗体位采集,MRI推荐T1、T2(含/不含脂肪抑制)及增强T1序列,影像解读应由肿瘤科、放射科和核医学专家多学科共同完成。
要点
- 所有肉眼肿瘤根治性放疗计划推荐使用多模态影像进行靶区勾画。
- 2-[18F]FDG-PET/CT应可获取,最好在治疗体位采集。
- MRI推荐T1、T2(含/不含脂肪抑制)及增强T1序列,最好在治疗体位采集。
核心结论
- 多模态影像应推荐用于所有肉眼肿瘤的根治性放疗计划制定。
- 影像采集、重建、解读和勾画中的不确定性或错误属系统误差,可能对整个放疗产生不利影响。
研究设计与样本
- 丹麦头颈癌多学科组(DAHANCA)放疗质量保证组于2020年1月组织全国研讨会,参与者来自肿瘤科、放射科和核医学。
- 研讨会达成国家指南并经DAHANCA批准,指南见补充材料。
主要发现
- PET和MRI可提供代谢、扩散、缺氧等多维信息以及解剖结构信息。
- 尚需大量工作以在患者个体化层面充分利用现有影像信息。
关键数值与推荐
- 推荐所有肉眼肿瘤根治性放疗计划使用多模态影像。
- 2-[18F]FDG-PET/CT应可获取,最好在治疗体位采集。
- MRI推荐序列为T1、T2(含和不含脂肪抑制)及增强T1,最好在治疗体位采集。
- 临床信息和影像解读应在肿瘤科、放射科和核医学专家多学科框架下完成。
临床怎么用
- 放疗靶区勾画应整合PET/CT与MRI多模态影像,并尽可能在治疗体位采集。
- 影像解读应由肿瘤科、放射科和核医学专家多学科共同完成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The definition of tumor involved volumes in patients with head and neck cancer poses great challenges with the increasing use of highly conformal radiotherapy techniques eg, volumetric modulated arc therapy and intensity modulated proton therapy. The risk of underdosing the tumor might increase unless great care is taken in the process. The information gained from imaging is increasing with both PET and MRI becoming readily available for the definition of targets. The information gained from these techniques is indeed multidimensional as one often acquire data on eg, metabolism, diffusion, and hypoxia together with anatomical and structural information. Nevertheless, much work remains to fully exploit the available information on a patient-specific level. Multimodality target definition in radiotherapy is a chain of processes that must be individually scrutinized, optimized and quality assured. Any uncertainties or errors in image acquisition, reconstruction, interpretation, and delineation are systematic errors and hence will potentially have a detrimental effect on the entire radiotherapy treatment and hence; the chance of cure or the risk of unnecessary side effects. Common guidelines and procedures create a common minimum standard and ground for evaluation and development. In Denmark, the treatment of head and neck cancer is organized within the multidisciplinary Danish Head and Neck Cancer Group (DAHANCA). The radiotherapy quality assurance group of DAHANCA organized a workshop in January 2020 with participants from oncology, radiology, and nuclear medicine from all centers in Denmark, treating patients with head and neck cancer. The participants agreed on a national guideline on imaging for target delineation in head and neck cancer radiotherapy, which has been approved by the DAHANCA group. The guidelines are available in the Supplementary. The use of multimodality imaging is being recommended for the planning of all radical treatments with a macroscopic tumor. 2-[18F]FDG-PET/CT should be available, preferable in the treatment position. The recommended MRI sequences are T1, T2 with and without fat suppression, and T1 with contrast enhancement, preferable in the treatment position. The interpretation of clinical information, including thorough physical examination as well as imaging, should be done in a multidisciplinary setting with an oncologist, radiologist, and nuclear medicine specialist.
引用
- Jensen K, Al-Farra G, Dejanovic D, et al. Imaging for Target Delineation in Head and Neck Cancer Radiotherapy. Semin Nucl Med. 2020. PMID: 33246540. doi:10.1053/j.semnuclmed.2020.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。